Novel oral anticoagulants: a review of new agents.

about

Rivaroxaban in patients with a recent acute coronary syndrome event: integration of trial findings into clinical practice Factor XI as a target for antithrombotic therapy The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variants.

P2860

Q26825230-63541F4F-FC9A-4A18-8014-90791349EA2D Q26865486-BCF0DE59-14B4-4D41-B050-1B9C3B38A2B5 Q50199930-E6507586-6B4B-4807-B533-953FE74729F8

P2860

Novel oral anticoagulants: a review of new agents.

Item

http://www.wikidata.org/entity/Q38128173

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Novel oral anticoagulants: a review of new agents.

@en

type

Item

label

Novel oral anticoagulants: a review of new agents.

@en

prefLabel

Novel oral anticoagulants: a review of new agents.

@en

P1476

Novel oral anticoagulants: a review of new agents

@en

P2093

Matthew A Wanat

http://www.w3.org/2001/XMLSchema#string

P2860

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Oral rivaroxaban for symptomatic venous thromboembolism

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.

Apixaban in patients with atrial fibrillation.

P304

103-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2013.07.2683

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Matthew A. Wanat

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255735102

http://www.w3.org/2001/XMLSchema#string

P698

23933899

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Novel oral anticoagulants: a review of new agents.

about

P2860

P2860

Novel oral anticoagulants: a review of new agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P921